{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:07:44Z","timestamp":1782821264009,"version":"3.54.5"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"Objective<\/jats:title>According to previous studies, the incidence of post-contrast acute kidney injury(PC-AKI) in diabetic is far higher than that in the general population. Therefore, we explored the relationship between the incidence of PC-AKI and different baseline serum creatinine (SCr) levels, and determined the relationship between PC-AKI and different types of contrast media (CMs), different doses of CM, and different examination methods in this specific population.<\/jats:p><\/jats:sec>Materials and methods<\/jats:title>Patients with diabetes in whom CM was used between 2010 and 2020 at our institution were included. Participants were identified according to the following three schemes: Scheme 1 (n=5911), SCr was detected before and within 72\u00a0h after using CM; Scheme 2 (n=2385), SCr was detected within 24\u00a0h before and within 24\u201372 h after using CM; and Scheme 3 (n=81), SCr was detected within 24\u00a0h before and within 0\u201324, 24\u201348, and 48\u201372 h after using CM. The incidence of PC-AKI with different types of CM, incidence of PC-AKI on digital subtraction angiography (DSA) and enhanced computed tomography (CT), proportion of PC-AKI with different doses of CM, and baseline SCr at different stages of PC-AKI were compared. Multivariate logistic regression analysis was used to explore risk factors for PC-AKI.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 29,081 patients were included in this study. The incidence of PC-AKI in Scheme 3 (22.22%) was higher than those in Schemes 1 (6.19%) and 2 (7.71%). The incidence of PC-AKI on DSA was higher than that on enhanced CT (8.30% vs. 5.80%; P<\/jats:italic>&lt;0.05). The incidence of PC-AKI in the increased-dose CM group was higher than that in the non-increased-dose CM group (7.9% vs. 5.7%; P<\/jats:italic>&lt;0.01). Moreover, there were differences in baseline SCr values at different stages of PC-AKI (P<\/jats:italic>&lt;0.01). Multivariate logistic regression analysis showed that hypertension, chronic kidney disease, heart failure, peripheral vascular disease, metformin, diuretics, and CM dose were risk factors for PC-AKI.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>The incidence of PC-AKI increased significantly with increasing time requirement and frequency of SCr detection. Moreover, before using CM, we should control the blood pressure and heart failure, stop using metformin and diuretics, and use CMs at the minimum dose to avoid PC-AKI.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1042312","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T05:02:34Z","timestamp":1673499754000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the relationship between post-contrast acute kidney injury and different baseline creatinine standards: A retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Jixiang","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiye","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwu","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3295176","article-title":"The mechanism of contrast-induced acute kidney injury and its association with diabetes mellitus","volume":"2020","author":"Li","year":"2020","journal-title":"Contrast Media Mol Imaging"},{"key":"B2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40620-018-0498-y","article-title":"Contrast medium induced acute kidney injury: A narrative review","volume":"31","author":"Pistolesi","year":"2018","journal-title":"J Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.03.008","article-title":"Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies","volume":"116","author":"Faucon","year":"2019","journal-title":"Eur J Radiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26466","article-title":"Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature","volume":"88","author":"Prasad","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.iccl.2020.02.001","article-title":"Contrast-induced acute kidney injury-definitions, epidemiology, and implications","volume":"9","author":"Azzalini","year":"2020","journal-title":"Interv Cardiol Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000368","article-title":"Contrast-induced nephropathy: Definition, epidemiology, and patients at risk","author":"Mehran","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"B7","unstructured":"Idf diabetes atlas 10th edition [Internet]. international diabetes federation2021"},{"key":"B8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ancard.2016.01.002","article-title":"[Contrast-induced nephropathy: An update]","volume":"65","author":"Spagnoli","year":"2016","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019192094","article-title":"Use of intravenous iodinated contrast media in patients with kidney disease: Consensus statements from the American college of radiology and the national kidney foundation","volume":"294","author":"Davenport","year":"2020","journal-title":"Radiology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-5246-5","article-title":"Post-contrast acute kidney injury - part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated esur contrast medium safety committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur Radiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.05.099","article-title":"Contrast-induced acute kidney injury","volume":"68","author":"McCullough","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4103\/1995-705X.125926","article-title":"Contrast-induced nephropathy","volume":"14","author":"Mohammed","year":"2013","journal-title":"Heart Views"},{"key":"B13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5527\/wjn.v9.i2.33","article-title":"Findings on intraprocedural non-contrast computed tomographic imaging following hepatic artery embolization are associated with development of contrast-induced nephropathy","volume":"9","author":"Soliman","year":"2020","journal-title":"World J Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.11817\/j.issn.1672-7347.2020.190191","article-title":"Clinical efficacy of danhong injection in preventing contrast-induced acute kidney injury based on propensity score matching method","volume":"45","author":"Wang","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/1319-2442.225199","article-title":"Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention","volume":"29","author":"Hossain","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000000215","article-title":"Risk prediction of contrast-induced nephropathy by acef score in patients undergoing coronary catheterization","volume":"17","author":"Capodanno","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.07.043","article-title":"Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction","volume":"44","author":"Marenzi","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.12.029","article-title":"Incidence, predictors, and impact on six-month mortality of three different definitions of contrast-induced acute kidney injury after coronary angiography","volume":"121","author":"Guillon","year":"2018","journal-title":"Am J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2013.03.007","article-title":"Prevention of contrast-induced nephropathy by n-acetylcysteine in critically ill patients: Different definitions, different results","volume":"28","author":"Chousterman","year":"2013","journal-title":"J Crit Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew213","article-title":"Contrast induced nephropathy in vascular surgery","volume":"117","author":"Wong","year":"2016","journal-title":"Br J Anaesth"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2017.03.003","article-title":"Intravenous contrast: Friend or foe? a review on contrast-induced nephropathy","volume":"24","author":"Do","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/08860220600683524","article-title":"Risk factors and therapy strategies for contrast-induced nephropathy","volume":"28","author":"Toprak","year":"2006","journal-title":"Ren Fail"},{"key":"B23","unstructured":"Manual on contrast media. version 10.3. reston, va: American college of radiology, 20182019"},{"key":"B24","article-title":"Comparative effects of different contrast media[Internet]","volume":"15","author":"Eng","year":"2015"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1805256","article-title":"Contrast-associated acute kidney injury","volume":"380","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-3-200902030-00006","article-title":"Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality","volume":"150","author":"Marenzi","year":"2009","journal-title":"Ann Intern Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2014.05.025","article-title":"Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention","volume":"66","author":"Victor","year":"2014","journal-title":"Indian Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11604-019-00850-2","article-title":"Guideline on the use of iodinated contrast media in patients with kidney disease 2018","volume":"38","author":"Isaka","year":"2020","journal-title":"Jpn J Radiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/0003319718754984","article-title":"The incidence, risk factors, and outcomes of contrast-induced nephropathy in patients with critical limb ischemia following lower limb angiography","volume":"69","author":"Cury","year":"2018","journal-title":"Angiology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12967-020-02574-8","article-title":"Contrast-induced nephropathy and oxidative stress: Mechanistic insights for better interventional approaches","volume":"18","author":"Kusirisin","year":"2020","journal-title":"J Transl Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"27K","DOI":"10.1016\/j.amjcard.2006.01.022","article-title":"Risk prediction of contrast-induced nephropathy","volume":"98","author":"McCullough","year":"2006","journal-title":"Am J Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcin.2013.06.016","article-title":"Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: Insights from the ncdr cath-pci registry","volume":"7","author":"Tsai","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2750173","article-title":"Prevalence and predictors of contrast-induced nephropathy (Cin) in patients with St-segment elevation myocardial infarction (Stemi) undergoing percutaneous coronary intervention (Pci): A meta-analysis","volume":"2019","author":"He","year":"2019","journal-title":"J Interv Cardiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23023","article-title":"Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure","volume":"42","author":"Qian","year":"2019","journal-title":"Clin Cardiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.iccl.2014.03.012","article-title":"Renal complications in patients undergoing peripheral artery interventions","volume":"3","author":"Goel","year":"2014","journal-title":"Interv Cardiol Clin"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1042312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T05:02:41Z","timestamp":1673499761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1042312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":35,"alternative-id":["10.3389\/fendo.2022.1042312"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1042312","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"article-number":"1042312"}}